We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.23B
AUM Growth
+$208M
Cap. Flow
+$191M
Cap. Flow %
4.51%
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181

Sector Composition

Rank Sector Weight
1 Energy 17.21%
2 Healthcare 16.93%
3 Financials 12.93%
4 Industrials 12.5%
5 Technology 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPKL
201
Spark I Acquisition Corp
SPKL
$101M
$722K 0.02%
66,832
IRON icon
202
Disc Medicine
IRON
$2.97B
$676K 0.02%
13,621
-636
-4% -$35.4K
NGNE icon
203
Neurogene
NGNE
$710M
$656K 0.02%
56,015
+23,281
+71% +$404K
CHTR icon
204
PUT
Charter Communications
CHTR
$18.8B
$654K 0.02%
20,500
+12,100
+144% +$4.33M
TSLA icon
205
Tesla
TSLA
$1.26T
$648K 0.02%
2,500
+2,000
+400% +$667K
PTGX icon
206
Protagonist Therapeutics
PTGX
$9.46B
$645K 0.02%
+13,340
New +$559K
HOG icon
207
PUT
Harley-Davidson
HOG
$2.67B
$642K 0.02%
240,000
+5,000
+2% +$134K
AMD icon
208
Advanced Micro Devices
AMD
$799B
$616K 0.01%
+6,000
New +$667K
PTON icon
209
PUT
Peloton Interactive
PTON
$2.38B
$588K 0.01%
290,500
-209,500
-42% -$1.64M
OCFT
210
DELISTED
OneConnect Financial Technology
OCFT
$558K 0.01%
+83,257
New +$369K
CC icon
211
PUT
Chemours
CC
$2.27B
$546K 0.01%
46,900
VERA icon
212
Vera Therapeutics
VERA
$2.3B
$541K 0.01%
22,525
+10,994
+95% +$353K
ONC
213
BeOne Medicines Ltd
ONC
$36.7B
$512K 0.01%
1,880
-14,319
-88% -$3.35M
TAL icon
214
TAL Education Group
TAL
$6.91B
$489K 0.01%
+37,000
New +$461K
AZN icon
215
AstraZeneca
AZN
$250B
$486K 0.01%
3,306
-27,418
-89% -$3.97M
META icon
216
PUT
Meta Platforms (Facebook)
META
$1.5T
$452K 0.01%
+16,000
New +$10.3M
ROIV icon
217
Roivant Sciences
ROIV
$25.4B
$432K 0.01%
42,819
-136,447
-76% -$1.48M
WRD
218
WeRide Inc
WRD
$1.94B
$425K 0.01%
+31,350
New +$535K
VSAT icon
219
PUT
Viasat
VSAT
$11.3B
$425K 0.01%
73,300
JANX icon
220
Janux Therapeutics
JANX
$982M
$406K 0.01%
+15,040
New +$567K
MLCO icon
221
Melco Resorts & Entertainment
MLCO
$2.14B
$405K 0.01%
+76,800
New +$432K
LRMR icon
222
Larimar Therapeutics
LRMR
$436M
$387K 0.01%
180,027
-8,516
-5% -$26.9K
BMRN icon
223
BioMarin Pharmaceuticals
BMRN
$11.9B
$372K 0.01%
5,258
-21,582
-80% -$1.45M
LYV icon
224
PUT
Live Nation Entertainment
LYV
$42.3B
$370K 0.01%
32,500
-182,900
-85% -$25M
HLF icon
225
PUT
Herbalife
HLF
$1.21B
$367K 0.01%
82,400

Similar funds

UBS O'Connor's Q1 2025 Portfolio in Review

As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

UBS O'Connor deployed $191M of net new capital in Q1 2025, opening 83 new positions and adding to 81 existing holdings. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Juniper Networks, an estimated $71.4M trimmed.

  • UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
  • UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
  • UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
  • UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
  • UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
  • UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
  • UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.